Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT02426281 · COMPLETED
Trial details
- NCT number
- NCT02426281
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-04
- Primary completion
- 2022-09-30
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.